Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00589849 · ClinicalTrials.gov registry record
T-Wave Alternans in Acute Myocardial Infarction: An Evaluation of the Time of Testing on Its Prognostic Accuracy
A clinical trial, sponsored by Creighton University.
- Completed
- Registry status
- 32
- Enrollment target
NCT00589849 is a clinical trial that has completed, run by Creighton University. The registered enrollment target is 32 participants.
The verdict
NCT00589849 has completed, sponsored by Creighton University.
- COMPLETED
- Registry status
- 32 participants
- Enrollment target
Study Summary
T-wave alternans is an electrocardiographic finding that has been shown to predict the occurrence of future cardiac arrhythmias in patients who have had a heart attack. What is unknown about T-wave alternans testing is when is the best time to perform the test. In most studies, T-wave alternans testing is conducted 4 weeks or more after a heart attack. It is unknown if T-wave alternans testing performed prior to hospital discharge in heart attack patients is reliable. The objective of this project is to determine the diagnostic accuracy of T-wave alternans testing performed prior to hospital discharge and again at 30 days after hospital discharge in patients who have suffered a heart attack.
Interventions
- PROCEDURE T-wave Alternans
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2006-05 |
| Est. Completion | 2011-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00589849
The ClinicalTrials.gov registry entry for NCT00589849 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Creighton University, which has 98 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which T-wave Alternans is the first listed.
NCT00589849 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00589849 about?
NCT00589849 is a clinical study titled "T-Wave Alternans in Acute Myocardial Infarction: An Evaluation of the Time of Testing on Its Prognostic Accuracy". T-wave alternans is an electrocardiographic finding that has been shown to predict the occurrence of future cardiac arrhythmias in patients who have had a heart attack. What is unknown about T-wave alternans testing is when is the best time to perform the test. In most studies, T-wave alternans test...
What is the current status of trial NCT00589849?
This trial is currently completed. The enrollment target is 32 participants. The study started on 2006-05. Estimated completion is 2011-05.
What interventions are being tested in trial NCT00589849?
The interventions under investigation include: T-wave Alternans (PROCEDURE).
Who is sponsoring clinical trial NCT00589849?
This trial is sponsored by Creighton University, which has 98 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.